Upgrade to SI Premium - Free Trial

Viatris Inc (VTRS)

10.63 -0.01 (0.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/24)

Latest Headlines

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 June 7, 2024 6:59 AM - PR NewsWire Form 4 Viatris Inc For: Jun 03 Filed by: Vivaldi Coelho Rogerio June 4, 2024 6:05 PM - SEC Filing Form 3 Viatris Inc For: Jun 03 Filed by: Vivaldi Coelho Rogerio June 4, 2024 6:00 PM - SEC Filing Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 4, 2024 6:59 AM - PR NewsWire Form 8-K Viatris Inc For: Jun 03 June 3, 2024 7:16 AM - SEC Filing Viatris Inc (VTRS) Appoints Rogerio Vivaldi Coelho to its Board June 3, 2024 6:59 AM - StreetInsider Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors June 3, 2024 6:59 AM - PR NewsWire Viatris to Participate in the Jeffries Global Healthcare Conference May 31, 2024 6:59 AM - PR NewsWire Form 4 Viatris Inc For: May 28 Filed by: Roman Brian May 28, 2024 6:00 PM - SEC Filing Form 144 Viatris Inc Filed by: Roman Brian May 28, 2024 4:11 PM - SEC Filing Increasing unusual put option volume: INDA INSM GPN CCI DLO CORT GME INMD VTRS May 28, 2024 10:06 AM - StreetInsider Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale May 21, 2024 7:12 PM - StreetInsider Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale May 21, 2024 6:59 AM - PR NewsWire Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor May 21, 2024 12:50 AM - StreetInsider Form 10-Q Viatris Inc For: Mar 31 May 9, 2024 4:05 PM - SEC Filing Form 8-K Viatris Inc For: May 09 May 9, 2024 7:45 AM - SEC Filing Viatris Inc (VTRS) Reports In-Line Q1 EPS; offers guidance May 9, 2024 7:01 AM - StreetInsider Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges May 9, 2024 6:59 AM - PR NewsWire Viatris to Participate in the BofA Securities 2024 Health Care Conference May 2, 2024 5:00 PM - PR NewsWire Viatris Expands Its Wellbeing Program With the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health May 1, 2024 6:31 PM - StreetInsider Viatris Inc (VTRS) Launches Unmind May 1, 2024 6:59 AM - StreetInsider Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health May 1, 2024 6:59 AM - PR NewsWire Form 10-K/A Viatris Inc For: Dec 31 April 26, 2024 4:32 PM - SEC Filing Form 4 Viatris Inc For: Apr 18 Filed by: Le Goff Corinne April 19, 2024 6:05 PM - SEC Filing Form 3 Viatris Inc For: Apr 15 Filed by: Le Goff Corinne April 19, 2024 6:00 PM - SEC Filing Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 April 16, 2024 4:30 PM - PR NewsWire Viatris Inc (VTRS) Appoints Corinne Le Goff as Chief Commercial Officer April 15, 2024 8:00 AM - StreetInsider Viatris Appoints Corinne Le Goff as Chief Commercial Officer April 15, 2024 8:00 AM - PR NewsWire Form 4 Viatris Inc For: Apr 02 Filed by: Malik Rajiv April 4, 2024 6:00 PM - SEC Filing Ocuphire Pharma (OCUP) Announces US Launch of RYZUMVl April 1, 2024 7:15 AM - StreetInsider Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris April 1, 2024 7:14 AM - Globe NewsWire Viatris Inc (VTRS) Announces Launch of RYZUMVl in the US April 1, 2024 6:59 AM - StreetInsider Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States April 1, 2024 6:59 AM - PR NewsWire Viatris (VTRS) PT Raised to $13 at Piper Sandler on latest Idorsia deals March 28, 2024 6:40 AM - StreetInsider Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline March 27, 2024 6:59 AM - PR NewsWire Idorsia and Viatris successfully close the transaction for the global research and development collaboration March 18, 2024 2:00 AM - StreetInsider Form 4 Viatris Inc For: Mar 13 Filed by: Mauro Anthony March 15, 2024 6:01 PM - SEC Filing Full Article List